tiprankstipranks
Advertisement
Advertisement

EBR Systems Files Delaware Charter Amendment to Activate Reverse Stock Split

Story Highlights
  • EBR Systems filed a Delaware charter amendment to implement a reverse stock split and related U.S. disclosure.
  • The move reshapes EBR’s capital structure as it promotes its unique WiSE wireless cardiac pacing technology globally.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
EBR Systems Files Delaware Charter Amendment to Activate Reverse Stock Split

Claim 30% Off TipRanks

EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:EBR) ) just unveiled an update.

EBR Systems has lodged an amended charter in Delaware to implement a previously approved reverse stock split, and has filed the associated disclosure with the U.S. securities regulator. The move marks a key corporate action for the ASX-listed cardiac device maker, potentially affecting its share structure and positioning as it advances commercialization of its WiSE wireless pacing technology.

The company continues to highlight that its WiSE system is the only wireless endocardial left-ventricular pacing technology currently in clinical use, and it remains investigational in most markets and only commercially available in the U.S. This corporate step may support EBR Systems’ efforts to bolster its capital markets profile as it targets broader adoption of its heart failure therapy platform.

The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.47 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.

More about EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh

EBR Systems, Inc. is a Silicon Valley-based medical technology company focused on treating cardiac rhythm disease through wireless cardiac pacing solutions. Its proprietary Wireless Stimulation Endocardially (WiSE) technology delivers endocardial left-ventricular pacing without traditional leads, targeting heart failure patients needing Cardiac Resynchronisation Therapy and potential future indications such as bradycardia and non-cardiac uses.

Average Trading Volume: 514,432

Technical Sentiment Signal: Sell

Current Market Cap: A$299.4M

See more data about EBR stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1